|
End-of-day quote
Nasdaq
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Franck Grimaud
PRN | Corporate Officer/Principal | 59 | 2015-11-30 |
Reinhard Kandera
DFI | Director of Finance/CFO | 56 | - |
Robert C. Seid
PRN | Corporate Officer/Principal | - | 2008-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 87 | 2006-07-04 | |
F. Weller Meyer
BRD | Director/Board Member | 83 | 2005-12-31 |
Richard Douglas
BRD | Director/Board Member | 73 | 2001-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.47% | -6.48% | +38.23% | -7.00% | 79.26B | |
| -1.99% | -1.22% | +511.53% | +27.44% | 58.56B | |
| +1.57% | +0.62% | -16.15% | -34.72% | 58.62B | |
| -0.56% | -3.68% | -11.53% | +25.63% | 48.75B | |
| -0.29% | -0.19% | +1.21% | +154.61% | 46.32B | |
| -0.55% | -2.11% | +49.23% | -15.66% | 32.12B | |
| -0.37% | -3.95% | +46.50% | +91.78% | 24.77B | |
| -1.91% | -6.22% | -2.91% | +151.66% | 21.5B | |
| -1.92% | -2.31% | +62.94% | +96.25% | 15.97B | |
| Average | -0.69% | -1.87% | +75.45% | +54.44% | 42.87B | |
| Weighted average by Cap. | -0.59% | -1.83% | +91.25% | +36.27% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
